Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas. Concentra Group Holdings Parent, Inc. was formerly a subsidiary of Select Medical Corporation.
Market Dominance | Explore Concentra's position as the largest occupational health services provider in the US, serving 200,000 employers across 41 states |
Financial Health | Delve into Concentra's robust financial outlook, with projected revenue growth to $2.3 billion by FY 2026 and improving EBITDA margins |
Growth Strategies | Uncover Concentra's three-pillar growth strategy: organic expansion, strategic acquisitions, and penetration into adjacent markets |
Analyst Perspectives | Discover varied analyst views on Concentra's potential, with price targets ranging from $27 to $33, suggesting upside from current levels |
Metrics to compare | CON | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCONPeersSector | |
---|---|---|---|---|
P/E Ratio | 18.7x | 19.5x | −0.5x | |
PEG Ratio | −0.57 | −0.10 | 0.00 | |
Price/Book | 8.1x | 5.2x | 2.6x | |
Price / LTM Sales | 1.4x | 2.5x | 3.3x | |
Upside (Analyst Target) | 31.8% | 14.8% | 43.4% | |
Fair Value Upside | Unlock | 21.9% | 7.1% | Unlock |